Search

everythinglearnresearchcommunity

for

Search:↓

The compound 4c effectively inhibits the enzyme linked to hair loss.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.

Finasteride increases CD8+ T cells in BPH tissues.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Combination drug therapies are more effective for high-risk BPS patients but have more side effects and costs.

DPP4-positive fibroblasts play a major role in producing proteins that lead to skin fibrosis.

5α-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT levels.

4-aminopyridine, a FDA-approved drug, speeds up skin wound healing and tissue regeneration.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

PADI4 enzyme slows down cell growth in developing hair follicles.

A new compound may effectively inhibit the enzyme linked to BPH and hair loss.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

5-alpha reductase inhibitors help with benign prostatic hyperplasia but don't cure it, and more research is needed.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Medicines called 5-alpha-reductase inhibitors, like finasteride and dutasteride, are useful for treating enlarged prostate and male pattern hair loss.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

Epristeride's metabolism in zebrafish helps improve doping detection methods.

DPP may help hair regrowth by improving blood vessel function under stress.

Trienones are more effective at inhibiting the enzyme linked to hair loss than dienones.